mk 0663 has been researched along with Liver Dysfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cannon, CP; Connors, LG; Curtis, SP; Goldkind, L; Laine, L; Yanqiong, Z | 1 |
Agrawal, NG; Alam, I; Cote, J; Dilzer, SC; Geer, LA; Gottesdiener, KM; Larson, PJ; Lasseter, KC; Matthews, CZ; Petty, KJ; Porras, AG; Rose, MJ; Woolf, EJ | 1 |
2 trial(s) available for mk 0663 and Liver Dysfunction
Article | Year |
---|---|
How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Hospitalization; Humans; Liver Diseases; Male; Middle Aged; Osteoarthritis; Pyridines; Risk Factors; Sulfones | 2009 |
Pharmacokinetics of etoricoxib in patients with hepatic impairment.
Topics: Administration, Oral; Aged; Area Under Curve; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Female; Humans; Liver Diseases; Male; Middle Aged; Pyridines; Sulfones | 2003 |